Purchase of naloxone nasal spray

Amneal Pharmaceuticals LLC has been awarded a contract by the New York State Office of Addiction Services and Supports. The contract, designated PA0004, carries a cumulative value of $8.0 million and is effective from September 1, 2026, through August 31, 2031. As the prime contractor, Amneal Pharmaceuticals LLC will deliver products and/or services to support the State's addiction services and support initiatives over this five-year performance period.

While the specific products and services to be delivered under this contract are not detailed in the available documentation, the contracting organization's focus on addiction services and supports suggests that the deliverables are likely related to pharmaceutical products, treatment resources, or support services aligned with New York State's substance use disorder prevention, treatment, and recovery objectives. Additional documentation would be required to specify the precise scope of work, performance metrics, and service delivery locations within New York State.